Baek, S.H., Park, S.J., Lee, H.G., 2010. D-psicose, a sweet monosaccharide, ameliorate hyperglycemia, and dyslipidemia in C57BL/6J db/db mice. Journal of food science 75, H49-53.
Braunstein, C.R., Noronha, J.C., Khan, T.A., Mejia, S.B., Wolever, T.M.S., Josse, R.G., Kendall, C.W.C., Sievenpiper, J.L., 2020. Effect of fructose and its epimers on postprandial carbohydrate metabolism: A systematic review and meta-analysis. Clinical Nutrition 39, 3308-3318.
Buemann, B., Toubro, S., Astrup, A., 1998. D-Tagatose, a stereoisomer of D-fructose, increases hydrogen production in humans without affecting 24-hour energy expenditure or respiratory exchange ratio. The Journal of nutrition 128, 1481-1486.
Chung, Y.M., Hyun Lee, J., Youl Kim, D., Hwang, S.H., Hong, Y.H., Kim, S.B., Jin Lee, S., Hye Park, C., 2012. Dietary D-psicose reduced visceral fat mass in high-fat diet-induced obese rats. Journal of food science 77, H53-58.
Collotta, D., Lucarini, L., Chiazza, F., Cento, A.S., Durante, M., Sgambellone, S., Chini, J., Baratta, F., Aragno, M., Mastrocola, R., Masini, E., Collino, M., 2018. Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose. Oxidative medicine and cellular longevity 2018, 5042428.
Crowther, M., Lim, W., Crowther, M.A., 2010. Systematic review and meta-analysis methodology. Blood 116, 3140-3146.
Donner, T.W., Magder, L.S., Zarbalian, K., 2010. Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol. Nutrition research (New York, N.Y.) 30, 801-806.
Ensor, M., Banfield, A.B., Smith, R.R., Williams, J., Lodder, R.A., 2015. Safety and Efficacy of D-Tagatose in Glycemic Control in Subjects with Type 2 Diabetes. Journal of endocrinology, diabetes & obesity 3.
Haas, M.J., Parekh, S., Kalidas, P., Richter, A., Warda, F., Wong, N.C.W., Tokuda, M., Mooradian, A.D., 2022. Insulin mimetic effect of D-allulose on apolipoprotein A-I gene. Journal of food biochemistry 46, e14064.
Han, Y., Kwon, E.Y., Choi, M.S., 2020. Anti-Diabetic Effects of Allulose in Diet-Induced Obese Mice via Regulation of mRNA Expression and Alteration of the Microbiome Composition. Nutrients 12.
Han, Y., Kwon, E.Y., Yu, M.K., Lee, S.J., Kim, H.J., Kim, S.B., Kim, Y.H., Choi, M.S., 2018. A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 10.
Hayashi, N., Iida, T., Yamada, T., Okuma, K., Takehara, I., Yamamoto, T., Yamada, K., Tokuda, M., 2010. Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects. Bioscience, biotechnology, and biochemistry 74, 510-519.
Higgins, J., 2011. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. www. cochrane-handbook. org.
Hollænder, P.L., Ross, A.B., Kristensen, M., 2015. Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies. Am J Clin Nutr 102, 556-572.
Iida, T., Hayashi, N., Yamada, T., Yoshikawa, Y., Miyazato, S., Kishimoto, Y., Okuma, K., Tokuda, M., Izumori, K., 2010. Failure of d-psicose absorbed in the small intestine to metabolize into energy and its low large intestinal fermentability in humans. Metabolism 59, 206-214.
Kanasaki, A., Iida, T., Murao, K., Shirouchi, B., Sato, M., 2020. D-Allulose enhances uptake of HDL-cholesterol into rat's primary hepatocyte via SR-B1. Cytotechnology 72, 295-301.
Kanasaki, A., Jiang, Z., Mizokami, T., Shirouchi, B., Iida, T., Nagata, Y., Sato, M., 2019. Dietary d-allulose alters cholesterol metabolism in Golden Syrian hamsters partly by reducing serum PCSK9 levels. Journal of Functional Foods 60, 103429.
Kimura, T., Kanasaki, A., Hayashi, N., Yamada, T., Iida, T., Nagata, Y., Okuma, K., 2017. d-Allulose enhances postprandial fat oxidation in healthy humans. Nutrition (Burbank, Los Angeles County, Calif.) 43-44, 16-20.
Lee, D., Han, Y., Kwon, E.Y., Choi, M.S., 2020. d-allulose Ameliorates Metabolic Dysfunction in C57BL/KsJ-db/db Mice. Molecules (Basel, Switzerland) 25.
Levin, G.V., Zehner, L.R., Saunders, J.P., Beadle, J.R., 1995. Sugar substitutes: their energy values, bulk characteristics, and potential health benefits. Am J Clin Nutr 62, 1161s-1168s.
Madison, B.B., 2016. Srebp2: A master regulator of sterol and fatty acid synthesis. Journal of lipid research 57, 333-335.
Mejia, E., Pearlman, M., 2019. Natural Alternative Sweeteners and Diabetes Management. Current diabetes reports 19, 142.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., PRISMA Group*, t., 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine 151, 264-269.
Nagata, Y., Kanasaki, A., Tamaru, S., Tanaka, K., 2015. d-Psicose, an Epimer of d-Fructose, Favorably Alters Lipid Metabolism in Sprague–Dawley Rats. Journal of Agricultural and Food Chemistry 63, 3168-3176.
Nagata, Y., Mizuta, N., Kanasaki, A., Tanaka, K., 2018. Rare sugars, d-allulose, d-tagatose and d-sorbose, differently modulate lipid metabolism in rats. Journal of the science of food and agriculture 98, 2020-2026.
Pepino, M.Y., Tiemann, C.D., Patterson, B.W., Wice, B.M., Klein, S., 2013. Sucralose affects glycemic and hormonal responses to an oral glucose load. Diabetes care 36, 2530-2535.
Police, S.B., Harris, J.C., Lodder, R.A., Cassis, L.A., 2009a. Effect of diets containing sucrose vs. D-tagatose in hypercholesterolemic mice. Obesity (Silver Spring, Md.) 17, 269-275.
Police, S.B., Harris, J.C., Lodder, R.A., Cassis, L.A., 2009b. Effect of Diets Containing Sucrose vs. D-tagatose in Hypercholesterolemic Mice. Obesity 17, 269-275.
Pongkan, W., Jinawong, K., Pratchayasakul, W., Jaiwongkam, T., Kerdphoo, S., Tokuda, M., Chattipakorn, S.C., Chattipakorn, N., 2021. D-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats. 60, 2047-2061.
Raben, A., Møller, B.K., Flint, A., Vasilaris, T.H., Christina Møller, A., Juul Holst, J., Astrup, A., 2011. Increased postprandial glycaemia, insulinemia, and lipidemia after 10 weeks' sucrose-rich diet compared to an artificially sweetened diet: a randomised controlled trial. Food Nutr Res 55.
Rother, K.I., Conway, E.M., Sylvetsky, A.C., 2018. How Non-nutritive Sweeteners Influence Hormones and Health. Trends in endocrinology and metabolism: TEM 29, 455-467.
Suez, J., Cohen, Y., Valdes-Mas, R., Mor, U., Dori-Bachash, M., Federici, S., Zmora, N., Leshem, A., Heinemann, M., Linevsky, R., Zur, M., Ben-Zeev Brik, R., Bukimer, A., Eliyahu-Miller, S., Metz, A., Fischbein, R., Sharov, O., Malitsky, S., Itkin, M., Stettner, N., Harmelin, A., Shapiro, H., Stein-Thoeringer, C.K., Segal, E., Elinav, E., 2022. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell 185, 3307-3328 e3319.
Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C.A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., Kuperman, Y., Harmelin, A., Kolodkin-Gal, I., Shapiro, H., Halpern, Z., Segal, E., Elinav, E., 2014. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514, 181-186.
Tanaka, M., Hayashi, N., Iida, T., 2019. Safety evaluation of 12-week continuous ingestion of D-allulose in borderline diabetes and type 2 diabetes. Fundamental Toxicological Sciences 6, 225-234.
Tanaka, M., Hayashi, N., Iida, T., Kuzawa, K., Naito, M., 2020a. Effects of Chocolate Containing D-allulose on Postprandial Lipid and Carbohydrate Metabolism in Young Japanese Women. Food Science and Technology Research 26, 623-632.
Tanaka M, H.N., Iida T, et al 2020. Effects of chocolate containing d-Allulose on postprandial lipid and carbohydrate metabolism in young japanese women. [J]. Food Science and Technology Research 26(5).
Tanaka, M., Kanasaki, A., Hayashi, N., Iida, T., Murao, K., 2020b. Safety and efficacy of a 48-week long-term ingestion of D-allulose in subjects with high LDL cholesterol levels. Fundamental Toxicological Sciences 7, 15-31.
Tanaka, M., Kanasaki, A., Hayashi, N., Iida, T., Murao, K., 2021. The influence of long-term ingestion of D-allulose in hypercholesterolemia patients under statin therapy. Fundamental Toxicological Sciences 8, 23-31.
Teysseire, F., Bordier, V., Budzinska, A., Van Oudenhove, L., Weltens, N., Beglinger, C., Wolnerhanssen, B.K., Meyer-Gerspach, A.C., 2023. Metabolic Effects and Safety Aspects of Acute D-allulose and Erythritol Administration in Healthy Subjects. Nutrients 15(2).
Tsukamoto, I., Hossain, A., Yamaguchi, F., Hirata, Y., Dong, Y., Kamitori, K., Sui, L., Nonaka, M., Ueno, M., Nishimoto, K., Suda, H., Morimoto, K., Shimonishi, T., Saito, M., Song, T., Konishi, R., Tokuda, M., 2014. Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose. Drug design, development and therapy 8, 1955-1964.